Menu
PoNS® IS NOW AVAILABLE IN THE US.
To view the Real World Evidence as presented at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting CLICK HERE.
To discuss the poster and the results further with Medical Affairs, or to learn how to obtain PoNS, call 877.564.0008.
Do you have MS patients with gait issues?
Stimulate their future.
PoNS®
Portable Neuromodulation
Stimulator
© Copyright 2022 | Helius Medical Technologies
Device
Menu
What is
PoNS® ?
PoNS® (short for Portable Neuromodulation Stimulator) is an innovative medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue.
Previously only available in Canada, PoNS® is now authorized in the US for the treatment of gait deficit due to mild-to-moderate symptoms of MS. The device is non-pharmaceutical, is safe and well tolerated and used in conjunction with a supervised therapeutic exercise program. Simply put, PoNS® works to improve gait deficiency.
By improving their walking, PoNS® can help your MS patients get back to living.
© Copyright 2022 | Helius Medical Technologies
Technology
Menu
How does
PoNS®
work?
The tongue’s dense nerve endings make it ideal for the stimulation that sends impulses to the brain stem and cerebellum, the body’s movement control center. A compromise to this neural network reduces its ability to effectively communicate with and control the body. The tongue stimulation, when combined with targeted therapeutic exercises, modulates the function of this network, improving its ability to control the body. This neuromodulation, when performed consistently and progressively over time results in sustained positive neuroplastic changes in the brain.
© Copyright 2022 | Helius Medical Technologies
Therapy
Menu
What is the
PoNS
Therapy™?
The PoNS Therapy™ is a comprehensive 14-week program that combines in-clinic and in-home use of the PoNS® device guided by a PoNS Trainer, focusing on balance and gait exercises.
When the stimulation is combined with a supervised therapeutic exercise program, changes occur in the neural network. Training helps to strengthen this network and facilitates the recovery of lost function.
DAILY PoNS THERAPY™ SCHEDULE
(6 days a week)
© Copyright 2022 | Helius Medical Technologies
Testimonials
Menu
GAINING CONFIDENCE
“Before PoNS® I didn’t want to go anywhere for risk of falling in front of people. I could not walk anywhere without holding onto something, like a wall. Since PoNS Therapy™ and thanks to my improved gait, I no longer need to hold my child’s hand at all times when walking. This alternative treatment has really made a difference in my life and has given me hope!
– A.H.*
In a real-world analysis of individuals with MS in Canada (N=42), 58.3% achieved at least a 4-point improvement in their Functional Gait Assessment (FGA).
Individual results and experiences may vary. Talk to your healthcare provider to see if PoNS® is right for you.
*Testimonials are from Canadian patients. PoNS® was approved for use in the US in March 2021. PoNS Therapy™ has been available in Canada since 2019.
OFF TO THE RACES
“When I got started with PoNS Therapy™ at the Surrey Neuroplasticity Clinic, I didn't know what to expect. While the process required commitment and discipline, I loved my PoNS® Trainer and the exercises! During the first two weeks I started to notice changes in my gait - my progress was so encouraging. Due to the improvements in my gait and balance, I am now able to enjoy an active lifestyle outdoors.”
– V.S.*
In a real-world analysis of individuals with MS in Canada (N=42), 58.3% achieved at least a 4-point improvement in their Functional Gait Assessment (FGA).
Individual results and experiences may vary. Talk to your healthcare provider to see if PoNS® is right for you.
*Testimonials are from Canadian patients. PoNS® was approved for use in the US in March 2021. PoNS Therapy™ has been available in Canada since 2019.
CLIMBING STAIRS TO SUCCESS
“Hope is a dangerous thing with MS, so I entered PoNS Therapy™ with cautious optimism. My caution quickly turned to encouragement as I saw positive signs early in treatment with improvements in my gait! Prior to my treatment I walked the stairs by stepping up with my right leg and dragging my left leg even, but now I experience periods every day where I walk up the stairs normally. I’ve experienced really encouraging results from my PoNS Therapy™.”
– K.B.*
In a real-world analysis of individuals with MS in Canada (N=42), 58.3% achieved at least a 4-point improvement in their Functional Gait Assessment (FGA).
Individual results and experiences may vary. Talk to your healthcare provider to see if PoNS® is right for you.
*Testimonials are from Canadian patients. PoNS® was approved for use in the US in March 2021. PoNS Therapy™ has been available in Canada since 2019.
THE PATH TO MANAGING MY MS
“PoNS Therapy™ was the next step for me in my MS journey after being diagnosed almost 15 years ago. It was exciting but is a lot of work and a big commitment. My wonderful PoNS® Trainer at Synaptic, my clinic in Calgary, worked with me diligently, answered all of my many questions, kept me motivated and provided different strategies when I got discouraged. At the end of the 14-week program I noticed an improvement in my gait, which I was very happy about. As a result of my improved gait, my balance and endurance are also better than when I started the program. The PoNS Therapy™ program is a wonderful journey to embark upon. Overall, it’s great to see we now have one more option to help us manage the path in our MS journey.”
– S.K.*
In a real-world analysis of individuals with MS in Canada (N=42), 58.3% achieved at least a 4-point improvement in their Functional Gait Assessment (FGA).
Individual results and experiences may vary. Talk to your healthcare provider to see if PoNS® is right for you.
*Testimonials are from Canadian patients. PoNS® was approved for use in the US in March 2021. PoNS Therapy™ has been available in Canada since 2019.
Contact
Menu
Have a question or comment?
Use the form to contact us and we will get back to you as soon as possible.
Helius Medical, Inc.
642 Newtown Yardley Rd., Suite 100
Newtown, PA 18940
Phone: +1 877-564-0008
Email: inquiries@heliusmedical.com
PoNS® and PoNS Therapy™ are trademarks of Helius Medical, Inc
INDICATIONS
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.
CONTRAINDICATIONS
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).
Electrical stimulation should not be used:
- If there is an active or suspected malignant tumor
- In areas of recent bleeding or open wounds
- In areas that lack normal sensation
The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.
*Testimonials are from Canadian patients. PoNS® was approved for use in the US in March, 2021. PoNS Therapy™ has been available in Canada since 2019.
Helius Medical Technologies is a publicly traded company on the Toronto Stock Exchange under symbol HSM and on the NASDAQ marketplace under symbol HSDT.
© Copyright 2022 | Helius Medical Technologies
Indications / Contraindications 
Contact Us
